This involves regular, liberal use of moisturizers and intermittent (e.g., twice-weekly) application of topical treatments to previously affected areas to stop new flares from starting [20]
Taking massive doses of Vitamin C may lead to digestive discomfort
Ye C, Lian G, Wang T, Chen A, Chen W, Gong J, et al
TUDCA has moderate evidence for cholestatic (bile-flow) conditions, but its benefit for the hepatocellular injury seen with fenbendazole is extrapolated rather than directly proven
Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
